Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Post time 2024-3-16 17:35:32

journal：Cancer Discovery

Authors：Marcelo V. Negrao; Haniel A. Araujo; Giuseppe Lamberti; Alissa J. Cooper; Neal S. Akhave; Teng Zhou; Lukas Delasos; J. Kevin Hicks; Mihaela Aldea; Gabriele Minuti; Jacobi Hines; Jacqueline V. Aredo; Michael J. Dennis; Turja Chakrabarti; Susan C. Scott; Paolo Bironzo; Matthias Scheffler; Petros Christopoulos; Albrecht Stenzinger; Jonathan W. Riess; So Yeon Kim; Sarah B. Goldberg; Mingjia Li; Qi Wang; Yun Qing; Ying Ni; Minh Truong Do; Richard Lee; Biagio Ricciuti; Joao Victor Alessi; Jing Wang; Blerina Resuli; Lorenza Landi; Shu-Chi Tseng; Mizuki Nishino; Subba R. Digumarthy; Waree Rinsurongkawong; Vadeerat Rinsurongkawong; Ara A. Vaporciyan; George R. Blumenschein; Jianjun Zhang; Dwight H. Owen; Collin M. Blakely; Giannis Mountzios; Catherine A. Shu; Christine M. Bestvina; Marina Chiara Garassino; Kristen A. Marrone; Jhanelle E. Gray; Sandip Pravin Patel; Amy L. Cummings; Heather A. Wakelee; Juergen Wolf; Giorgio Vittorio Scagliotti; Federico Cappuzzo; Fabrice Barlesi; Pradnya D. Patil; Leylah Drusbosky; Don L. Gibbons; Funda Meric-Bernstam; J. Jack Lee; John V. Heymach; David S. Hong; Rebecca S. Heist; Mark M. Awad; Ferdinandos Skoulidis

Published date：2023-7-7

DOI：10.1158/2159-8290.cd-22-1420

PDF link：https://aacrjournals.org/cancerd ... 0148/cd-22-1420.pdf

Article link：http://dx.doi.org/10.1158/2159-8290.cd-22-1420

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2024-3-16 17:35:33

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AACR] Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC Copy